Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals.
BMC Public Health 2016;
16:994. [PMID:
27645935 PMCID:
PMC5029046 DOI:
10.1186/s12889-016-3671-z]
[Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2016] [Accepted: 09/15/2016] [Indexed: 01/16/2023] Open
Abstract
Background
While the public health benefits of new HCV treatments depend on treatment adherence, particularly among people who inject drugs (PWID), several social and medical factors can jeopardize treatment adherence. The aim of this study is to examine the qualitative literature on facilitators to HCV treatment adherence among PWID.
Methods
We searched six databases to identify qualitative research studies on HCV treatment adherence facilitators among PWID. Two reviewers independently extracted and analyzed data using PRISMA guidelines and the CASP tool to evaluate study quality.
Results
From ten studies representing data from 525 participants, three major themes emerged across studies: logistical facilitators within health systems enhanced HCV treatment adherence, positive social interactions between PWID and staff provided positive feedback during treatment, and HCV treatment may complicate the addiction recovery process.
Conclusions
Although PWID face several barriers to adherence, we identified treatment adherence facilitators that could be incorporated into clinical practice.
Electronic supplementary material
The online version of this article (doi:10.1186/s12889-016-3671-z) contains supplementary material, which is available to authorized users.
Collapse